---
title: "Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations"
date: "2025-02-08 09:40:00"
summary: "Reporter NameGray William GarrettRelationshipChief Financial OfficerTypeSellAmount$271,983SEC FilingForm 4Checkpoint Therapeutics' Chief Financial Officer, William Garrett Gray, sold 74,110 shares of common stock on February 6, 2025, at a weighted average price of $3.67 per share, totaling $271,983. This sale was conducted to satisfy tax withholding obligations related to the vesting of..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Gray William Garrett |
| --- | --- |
| Relationship | Chief Financial Officer |
| Type | Sell |
| Amount | $271,983 |
| SEC Filing | [Form 4](https://www.sec.gov/Archives/edgar/data/1692961/000110465925010662/xslF345X05/tm255932-1_4seq1.xml) |

Checkpoint Therapeutics' Chief Financial Officer, William Garrett Gray, sold 74,110 shares of common stock on February 6, 2025, at a weighted average price of $3.67 per share, totaling $271,983. This sale was conducted to satisfy tax withholding obligations related to the vesting of 187,200 shares. Following this transaction, Gray directly owns 1,458,644 shares of Checkpoint Therapeutics' common stock.

SEC Filing: [Checkpoint Therapeutics, Inc. [ CKPT ] - Form 4 - Feb. 07, 2025](https://www.sec.gov/Archives/edgar/data/1692961/000110465925010662/xslF345X05/tm255932-1_4seq1.xml)

[TradingView](https://www.tradingview.com/news/tradingview:77a45b9731b4d:0-checkpoint-therapeutics-cfo-sells-shares-to-cover-tax-obligations/)
